Two Sigma Advisers’s Adverum Biotechnologies ADVM Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$23K Buy
+10,681
New +$23K ﹤0.01% 2288
2024
Q3
Sell
-22,901
Closed -$157K 2267
2024
Q2
$157K Buy
22,901
+6,731
+42% +$46.2K ﹤0.01% 2257
2024
Q1
$229K Sell
16,170
-30,060
-65% -$425K ﹤0.01% 2171
2023
Q4
$348K Sell
46,230
-3,040
-6% -$22.9K ﹤0.01% 2057
2023
Q3
$739K Buy
49,270
+6,550
+15% +$98.3K ﹤0.01% 1650
2023
Q2
$679K Sell
42,720
-24,879
-37% -$396K ﹤0.01% 1696
2023
Q1
$485K Sell
67,599
-5,471
-7% -$39.2K ﹤0.01% 1959
2022
Q4
$423K Sell
73,070
-32,110
-31% -$186K ﹤0.01% 1945
2022
Q3
$999K Sell
105,180
-45,280
-30% -$430K ﹤0.01% 1518
2022
Q2
$1.81M Buy
150,460
+130
+0.1% +$1.56K 0.01% 1271
2022
Q1
$1.97M Sell
150,330
-39,650
-21% -$519K 0.01% 1266
2021
Q4
$3.34M Buy
189,980
+13,290
+8% +$234K 0.01% 948
2021
Q3
$3.83M Buy
176,690
+79,170
+81% +$1.72M 0.01% 912
2021
Q2
$3.41M Buy
97,520
+8,030
+9% +$281K 0.01% 1042
2021
Q1
$8.82M Sell
89,490
-3,680
-4% -$363K 0.02% 630
2020
Q4
$10.1M Buy
93,170
+1,350
+1% +$146K 0.03% 561
2020
Q3
$9.46M Buy
91,820
+90,660
+7,816% +$9.34M 0.03% 546
2020
Q2
$242K Sell
1,160
-540
-32% -$113K ﹤0.01% 2192
2020
Q1
$166K Sell
1,700
-110
-6% -$10.7K ﹤0.01% 2215
2019
Q4
$209K Buy
+1,810
New +$209K ﹤0.01% 2173
2019
Q3
Sell
-7,540
Closed -$897K 2203
2019
Q2
$897K Sell
7,540
-7,450
-50% -$886K ﹤0.01% 1573
2019
Q1
$785K Sell
14,990
-8,300
-36% -$435K ﹤0.01% 1621
2018
Q4
$734K Buy
23,290
+1,920
+9% +$60.5K ﹤0.01% 1626
2018
Q3
$1.29M Sell
21,370
-710
-3% -$43K ﹤0.01% 1408
2018
Q2
$1.17M Buy
22,080
+9,310
+73% +$493K ﹤0.01% 1544
2018
Q1
$741K Buy
12,770
+6,020
+89% +$349K ﹤0.01% 1667
2017
Q4
$236K Buy
+6,750
New +$236K ﹤0.01% 2030
2016
Q3
Sell
-4,420
Closed -$140K 2193
2016
Q2
$140K Buy
4,420
+1,470
+50% +$46.6K ﹤0.01% 1931
2016
Q1
$153K Buy
2,950
+1,460
+98% +$75.7K ﹤0.01% 1880
2015
Q4
$142K Sell
1,490
-340
-19% -$32.4K ﹤0.01% 1733
2015
Q3
$158K Buy
+1,830
New +$158K ﹤0.01% 1680